Hostname: page-component-848d4c4894-x24gv Total loading time: 0 Render date: 2024-05-21T07:39:23.921Z Has data issue: false hasContentIssue false
  • English
  • Français

A comparison of live and inactivated influenza A (H1N1) virus vaccines

2. Long-term immunity

Published online by Cambridge University Press:  15 May 2009

A. Clark ,
C. W. Potter ,
R. Jennings ,
J. P. Nicholl ,
A. F. Langrick ,
G. C. Schild ,
J. M. Wood  and
D. A. J. Tyrrell
A. Clark
Affiliation:
Departments of Medical Microbiology, Virology and Community Medicine, University of Sheffield Medical School, Beech Hill Road, Sheffield, 510 2RX
C. W. Potter
Affiliation:
Departments of Medical Microbiology, Virology and Community Medicine, University of Sheffield Medical School, Beech Hill Road, Sheffield, 510 2RX
R. Jennings
Affiliation:
Departments of Medical Microbiology, Virology and Community Medicine, University of Sheffield Medical School, Beech Hill Road, Sheffield, 510 2RX
J. P. Nicholl
Affiliation:
Departments of Medical Microbiology, Virology and Community Medicine, University of Sheffield Medical School, Beech Hill Road, Sheffield, 510 2RX
A. F. Langrick
Affiliation:
Health Centre, University of Birmingham, Birmingham, B15 2TJ
G. C. Schild
Affiliation:
Division of Viral Products, National Institute for Biological Standardization and Control, Holly Hill, Hampstead, London, NW3 6RB
J. M. Wood
Affiliation:
Division of Viral Products, National Institute for Biological Standardization and Control, Holly Hill, Hampstead, London, NW3 6RB
D. A. J. Tyrrell
Affiliation:
Division of Communicable Diseases, Medical Research Council, Clinical Research Centre, Watford Road, Harrow, HA1 3UJ
Rights & Permissions [Opens in a new window]

Summary

Core share and HTML view are not available for this content. However, as you have access to this content, a full PDF is available via the ‘Save PDF’ action button.

Groups of volunteers were immunized with one of three influenza virus vaccines, and the resistance to challenge infection with attenuated influenza A (H1N1) virus was measured 8 months later. The vaccines were aqueous subunit influenza A/USSR/77 (H1N1) vaccine, aqueous subunit influenza B/Hong Kong/73 vaccine, or attenuated influenza virus A (H1N1) vaccine. The B virus vaccine was included as a control to assess the incidence of natural A virus infection during the study period. A proportion of the B virus vaccinees had pre-existing A (H1N1) virus antibody and were used to study the immunity conferred by natural infection to the live virus challenge. The serum antibody responses were measured at 1 and 8 months after immunization. The results showed that all the vaccines induced serum HI antibody in a proportion of the volunteers; however, after 1 month, higher titres of serum antibody were found in volunteers given inactivated A vaccine than in those given live attenuated A virus vaccine. Eight months post-immunization the titres of serum antibody in volunteers given inactivated vaccine had declined significantly, but there were no changes in the antibody titres of those given live virus vaccine. The incidence of infection by the challenge virus at 8 months post-immunization was directly related to the serum antibody titres 1 month post-immunization; no evidence was obtained to suggest that those given live virus vaccine had a more solid immunity than those given inactivated vaccine.

Type
Research Article
Information
Journal of Hygiene , Volume 90 , Issue 3 , June 1983 , pp. 361 - 370
Copyright
Copyright © Cambridge University Press 1983

References

REFERENCES

Beare, A. S., Hobson, D., Reed, S. E. & Tyrrell, D. A. J. (1968). A comparison of live and killed influenza virus vaccines. Lancet, ii, 418–420.CrossRefGoogle Scholar
Brady, M. I. & Furminger, I. G. S. (1976). A surface antigen influenza vaccine. I. Purification of haemagglutinin and neuraminidase proteins. Journal of Hygiene 77, 161–180.Google Scholar
Clark, A., Potter, C. W., Jennings, R., Nicholl, J. P., Langrick, A. F., Schild, G. C., Wood, J. M. & Tyrrell, D. A. J. (1983). A comparison of live and inactivated influenza A (H1N1) virus vaccines. 1. Short-term immunity. Journal of Hygiene 90, 351–359.Google Scholar
Freestone, D. S., Hamilton-Smith, S., Schild, G. C., Buckland, R., Chinn, S. & Tyrell, D. A. J. (1972). Antibody response and resistance to challenge in volunteers vaccinated with live attenuated, detergent-split, and oil adjuvant A2/Hong Kong/68 (H3N2) influenza vaccines. Journal of Hygiene 70, 531–543.CrossRefGoogle ScholarPubMed
Hobson, D., Beare, A. S. & Ward-Gardner, A. (1972). Haemagglutination-inhibiting serum antibody titres as an index of response of volunteers to intranasal infection with live, attenuated strains of influenza virus. Proceedings of the Symposium on Live Influenza Vaccines, Zagreb, 1971, pp. 73–84. Yugoslav Academy of Sciences and Arts.Google Scholar
Kasel, J. A., Hume, E. B., Fulk, R. V., Togo, Y., Huber, M. & Hornick, R. B. (1969). Antibody responses in nasal secretions of serum of elderly persons following local or parental administration of inactivated influenza virus vaccine. Journal of Immunology 102, 555–562.Google Scholar
Meikeljohn, G., Kempe, C. H., Tahalman, W. G. & Lennette, E. H. (1952). Evaluation of monovalent influenza vaccine. Observations during an influenza A-prime epidemic. American Journal of Hygiene 55, 12–21.Google Scholar
Murphy, H. B., Chalhub, E. G., Nsinoff, S. R., Dasel, J. R. & Chanock, R. M. (1973). Temperature-sensitive mutants of influenza virus. III. Further characterization of the ts-1 (E) influenza recombinant (H3N2) virus in man. Journal of Infectiou Diseases 128, 479–487.Google Scholar
Potter, C. W., Jenntngs, R., McLaren, C. & Clark, A. (1975). Immune response of volunteers to intranasal inoculation with freeze-dried influenza A/Hong Kong/68 vaccine. Journal of Biological Standardization 3, 41–50.CrossRefGoogle Scholar
Potter, C. W., Jennings, R., Phair, J. P., Clark, A. & Stuart-Harris, C. H. (1977). Dose-response relationship after immunization of volunteers with a new, surface-antigen-adsorbed influenza virus vaccine. Journal of Infectioas Diseases 135, 423–431.CrossRefGoogle ScholarPubMed
Potter, C. W. & Oxford, J. S. (1979). Determinants of immunity to influenza infection in man. British Medical Bulletin 35, 69–75.Google Scholar
Van Voorthuizen, F., Jens, D. & Saes, F. (1981). Characterization and clinical evaluation of live Influenza A vaccine prepared from a recombinant of the A/USSR/77 (H1N1) and the cold-adapted A/ANN ARBOR/6/60 (H2N2) strains. Antiviral Research 1, 107–122.Google Scholar
Waldman, R. H., Kasel, J. A., Fulk, R. V., Mann, J. J., Togo, Y., Hornick, R. B., Heiner, G. T. & Dawkins, A. T. (1968). Influenza antibody in human respiratory secretions after subcutaneous and respiratory immunization with inactivated virus. Nature 218, 594–595.CrossRefGoogle Scholar
World Health Organization Expert Committee On Influenza (1953). First report W.H.O. Technical Report Series no. 64, Geneva, World Health Organization.Google Scholar